Patent details

EP2092935 Title: Pharmaceutical compositions for the treatment of asthma

Basic Information

Publication number:
EP2092935
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP090061102
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Pharmaceutical compositions for the treatment of asthma
French Title of Invention:
Compositions pharmaceutiques pour le traitement de l'asthme
German Title of Invention:
Pharmazeutische Zusammensetzungen zur Behandlung von Asthma
SPC Number:

Dates

Filing date:
27/08/2002
Grant date:
30/03/2011
EP Publication Date:
30/03/2011
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
26/08/2009
EP B1 Publication Date:
30/03/2011
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
27/08/2014
Expiration date:
27/08/2022
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
09/07/2012
 
 

Name:
MERCK SHARP & DOHME CORP.
Address:
EAST LINCOLN AVENUE 126, RAHWAY, NEW JERSEY 07065, United States (US)

History of Owners

From:
27/08/2002
To:
08/07/2012

Name:
Schering Corporation
Address:
2000 Galloping Hill Road, Kenilworth, NJ 07033-0530, United States (US)

Agent

Name:
MARKS & CLERK LLP
From:
25/05/2011
Address:
BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)
To:

Inventor

1

Name:
Sequeira Joel A.
Address:
United States (US)

2

Name:
Hart John L.
Address:
United States (US)

3

Name:
Sharpe Stefan A.
Address:
United States (US)

Priority

Priority Number:
315386 P
Priority Date:
28/08/2001
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 9/12;
Filing date Document type Number of pages
12/08/2022 Request For Change 1
02/09/2022 Outgoing Correspondence 56